Theodore A G Smith

Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice

B. Trapnell, D. Kayda, M. Kaleko, 1993, Nature Genetics.

Targeting Adenoviral Vectors by Using the Extracellular Domain of the Coxsackie-Adenovirus Receptor: Improved Potency via Trimerization

P. Ryan, M. Kaleko, S. Stevenson, 2002, Journal of Virology.

In vivo hepatic adenoviral gene delivery occurs independently of the coxsackievirus-adenovirus receptor.

M. Rollence, M. Kaleko, S. Stevenson, 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

Adenovirus serotype 5 fiber shaft influences in vivo gene transfer in mice.

G. Nemerow, M. Rollence, M. Kaleko, 2003, Human Gene Therapy.

Section Review: Biologicals & Immunologicals: Gene therapy for haemophilia

Theodore A G Smith, 1995 .

Effect of adenovirus serotype 5 fiber and penton modifications on in vivo tropism in rats.

S. J. White, S. Nicklin, S. Stevenson, 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

Receptor interactions involved in adenoviral-mediated gene delivery after systemic administration in non-human primates.

J. Markovits, M. Rollence, M. Kaleko, 2003, Human gene therapy.

In vivo gene delivery and expression of physiological levels of functional human factor VIII in mice.

M. Kaleko, S. Connelly, K. Zaret, 1995, Human gene therapy.